Adenoma, Oxyphilic: A usually benign glandular tumor composed of oxyphil cells, large cells with small irregular nuclei and dense acidophilic granules due to the presence of abundant MITOCHONDRIA. Oxyphil cells, also known as oncocytes, are found in oncocytomas of the kidney, salivary glands, and endocrine glands. In the thyroid gland, oxyphil cells are known as Hurthle cells and Askanazy cells.Adenoma: A benign epithelial tumor with a glandular organization.Oxytocin: A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION.Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.Adenoma, Pleomorphic: A benign, slow-growing tumor, most commonly of the salivary gland, occurring as a small, painless, firm nodule, usually of the parotid gland, but also found in any major or accessory salivary gland anywhere in the oral cavity. It is most often seen in women in the fifth decade. Histologically, the tumor presents a variety of cells: cuboidal, columnar, and squamous cells, showing all forms of epithelial growth. (Dorland, 27th ed)Adenoma, Villous: An adenoma of the large intestine. It is usually a solitary, sessile, often large, tumor of colonic mucosa composed of mucinous epithelium covering delicate vascular projections. Hypersecretion and malignant changes occur frequently. (Stedman, 25th ed)Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.Adrenocortical Adenoma: A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE.Adenoma, Liver Cell: A benign epithelial tumor of the LIVER.Alcohol-Related Disorders: Disorders related to or resulting from abuse or mis-use of alcohol.Growth Hormone-Secreting Pituitary Adenoma: A pituitary tumor that secretes GROWTH HORMONE. In humans, excess HUMAN GROWTH HORMONE leads to ACROMEGALY.Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.Colonic Polyps: Discrete tissue masses that protrude into the lumen of the COLON. These POLYPS are connected to the wall of the colon either by a stalk, pedunculus, or by a broad base.Adenoma, Acidophil: A benign tumor, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumors may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhea. (Dorland, 27th ed)Colonoscopy: Endoscopic examination, therapy or surgery of the luminal surface of the colon.Adenomatous Polyps: Benign neoplasms derived from glandular epithelium. (From Stedman, 25th ed)Prolactinoma: A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.Adenoma, Basophil: A small tumor of the anterior lobe of the pituitary gland whose cells stain with basic dyes. It may give rise to excessive secretion of ACTH, resulting in CUSHING SYNDROME. (Dorland, 27th ed)Adrenal Cortex Neoplasms: Tumors or cancers of the ADRENAL CORTEX.Adenomatous Polyposis Coli: A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood.
(1/183) Expression of somatostatin receptors in oncocytic (Hurthle cell) neoplasia of the thyroid.

Ten consecutive patients with Hurthle cell lesions of the thyroid (nodule/adenoma/carcinoma) were studied by (111)In-DTPA-D-Phe1-octreotide scintigraphy. Octreotide scintigraphy localized the primary Hurthle cell tumour in eight patients as distinct areas of increased uptake of radionuclide. Two patients with Hurthle cell carcinoma, previously thyroidectomized, had their metastases visualized by octreotide scintigraphy. Northern analyses showed expression of multiple somatostain receptor subtypes. Visualization of the Hurthle cell tumour may be due to a higher expression of somatostatin receptors in the lesions than in surrounding normal thyroid tissue. The tissue/blood (111)In concentration ratios for tumour samples from five patients showed clearly higher values than observed for normal connective tissue, muscle or lymph nodes. A relatively high uptake of (111)In was also observed in goiter tissue, which may lead to misinterpretations. The main indication for octreotide scintigraphy in patients with Hurthle cell carcinoma is suspicion of metastatic disease.  (+info)

(2/183) Adrenocortical oncocytoma.

The histopathology and ultrastructural features of an adrenocortical oncocytoma are reported. The tumour was discovered incidentally during investigation for hypertension in a 72 year old female. Oncocytic tumours of the adrenal cortex are rare, with only 20 examples described in English language reports. Most have been non-functioning and benign, like the present example. Molecular studies may help assess the significance of oncocytic change in the pathogenesis and behaviour of oncocytic neoplasms.  (+info)

(3/183) Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.

Making a histologic distinction between Hurthle cell adenomas and carcinomas sometimes may be difficult. We analyzed a series of Hurthle cell lesions to determine whether specific histologic features and expression of Ki67 and cyclin D1 could be useful in distinguishing Hurthle cell adenomas from carcinomas. Formalin-fixed, paraffin-embedded tissues from 128 Hurthle cell neoplasms, including 59 adenomas; 55 carcinomas; and 14 tumors classified as neoplasms of uncertain malignant behavior (UMB), which had equivocal capsular invasion but no vascular invasion, were analyzed for expression of Ki67 and cyclin D1 by immunostaining. The distribution of immunoreactivity for Ki67 with antibody MIB-1 was analyzed by quantifying the percentage of positive nuclei that was expressed as the labeling index. None of the patients with adenomas or UMB tumors developed recurrent or metastatic disease after a mean follow-up of 7.8 and 7.9 years, respectively. Of the 55 patients with Hurthle cell carcinoma, 19 were associated with metastatic disease, 13 of whom died with disease. No patient with a Hurthle cell carcinoma without vascular invasion developed metastatic disease. The mean tumor size for Hurthle cell carcinomas (4.8 cm) was significantly larger than that of Hurthle cell adenomas (3.1 cm) or UMB tumors (3.7 cm). No patient with a Hurthle cell tumor smaller than 3.5 cm developed metastatic disease, even when vascular invasion was present. The Ki67 labeling index in Hurthle cell carcinomas (10.0 +/- 1.2) was 3-fold higher than in Hurthle cell adenomas (3.2 +/- 0.3). The Ki67 labeling index in the UMB group was 5.0 +/- 0.7. Cyclin D1 showed diffuse nuclear staining in 1 of the 59 (1.7%) Hurthle cell adenomas, in 10 of the 55 (18%) Hurthle cell carcinomas, and in none of the UMB tumors. In summary, analyses of the cell cycle proteins Ki67 and cyclin D1 in Hurthle cell thyroid neoplasms indicate that these markers may assist in distinguishing some Hurthle cell carcinomas from adenomas. Among the Hurthle cell carcinomas, large tumor size and vascular invasion are associated with clinically aggressive tumors. Our study also suggests that Hurthle cell neoplasms with only equivocal capsular invasion and no vascular invasion should behave in a benign manner.  (+info)

(4/183) Bilateral renal oncocytoma in a Greyhound dog.

A bilateral, locally invasive renal oncocytoma was diagnosed in a 10-year-old spayed female Greyhound dog. The diagnosis was based on positive staining of the tumor with the periodic acid-Schiff reaction prior to diastase treatment, on the immunohistochemical expression of cytoplasmic cytokeratin, and on the prominence of mitochondria in the tumor cells.  (+info)

(5/183) VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.

To elucidate the role of somatic alterations for renal cancer etiology and prognosis, we analyzed 227 sporadic renal epithelial tumors for mutations and hypermethylations in the von Hippel-Lindau tumor suppressor gene VHL. Tumors were classified according to the recommendations of the Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Somatic VHL mutations were identified by PCR, single-strand conformation polymorphism analysis, and sequencing, and hypermethylations were identified by restriction enzyme digestion and Southern blotting. Frequencies of VHL alterations were established, and an association with tumor type or tumor type and tumor stage was evaluated. VHL mutations and hypermethylations were identified in 45% of clear cell renal cell carcinomas (CCRCCs) and occasionally (3 of 28) in papillary (chromophilic) renal cell carcinomas (RCCs). Lack of VHL mutations and hypermethylations in chromophobe RCCs and oncocytomas was statistically significant (P = 0.0001 and P = 0.0004, respectively). RCCs carrying VHL alterations showed, in nine cases (12%), mutations at a hot spot involving a thymine repeat (ATT.TTT) in exon 2. Tumor staging was critical to the VHL mutation/hypermethylation detection rate in CCRCCs shown by separate evaluation of patients from medical centers in Munich, Heidelberg, and Mainz. The spectrum of pT1, pT2, and pT3 CCRCCs and the VHL mutation/hypermethylation detection rate varied among these three groups. Altogether, VHL alterations were significantly associated with pT3 CCRCCs (P = 0.009). This is the first evidence of frequent somatic VHL mutations at a particular site within exon 2 and an association of VHL mutations/hypermethylations with a standard prognostic factor.  (+info)

(6/183) Hurthle cell adenoma diagnosed by core needle biopsy in a male patient.

Hurthle cell adenomas (HCAs) are a rare and potentially lethal variant of follicular tumors of the thyroid. Considerable controversy exists regarding potential risk factors, diagnosis, and treatment of HCAs. The authors report the case of a 38-year-old male patient with an 8.3 cm x 3.5 cm HCA. Diagnosis was made preoperatively from a core needle biopsy and confirmed postoperatively on frozen section. Treatment consisted of a right lobectomy.  (+info)

(7/183) Immunohistochemical and ultrastructural study of clinically nonfunctioning pituitary adenomas.

Sixty-five clinically nonfunctioning pituitary adenomas were studied by immunohistochemistry, and 12 cases were also analyzed by electron microscopy. Thirty-nine cases (60%) were immunohistochemically identified as hormone-producing adenomas. Six adenomas produced multiple hormones. Electron microscopy found seven null cell adenomas and five oncocytomas. The oncocytomas had a significantly higher incidence of hormone expression that the null cell adenomas. These results indicate that clinically nonfunctioning pituitary adenomas produce hormones, even though blood hormone levels are normal or low. Furthermore, the evidence of multihormonal production implies that two or more cell lineages including a protein hormone-producing type and a glycoprotein hormone-producing type may exist in the same nonfunctioning pituitary adenoma.  (+info)

(8/183) Bronchial oncocytoma.

CONTEXT: Oncocytomas are generally small and present slow growth. Finding of the tumor usually occurs incidentally. Their incidence is higher among male patients. Oncocytomas in mucous bronchial glands are extremely rare. CASE REPORT: A 35-year-old male who presented bronchial oncocytoma. The tumor was found after bronchoscopy that investigated an atelectasis of the upper left lobe. Histological examination with optical microscopy revealed a mature neoplasm formed by ovoid cells with thin, granular, eosinophilic cytoplasm and small nuclei similar to oncocytes. Electron microscopy showed mitochondrial hyperplasia. A three-year follow-up after thoracotomy followed by lobectomy and removal of the bronchial tumor was uneventful.  (+info)

*  Oncocytoma
The salivary gland oncocytoma is a well-circumscribed, benign neoplastic growth also called an oxyphilic adenoma. It comprises ... Thyroid oncocytomas can be benign (adenomas) or malignant (carcinomas). Grossly, oncocytic adenomas are encapsulated, solid ... The gross appearance of a minimally invasive oncocytic carcinoma is indistinguishable to that of an adenoma, while widely ... There are no reliable cytologic features which distinguish oncocytic adenomas from carcinomas and the only criterion for a ...
*  Oncocyte
... may be found as a less common salivary gland neoplasm also known as Oxyphilic Adenoma. Renal oncocytoma, a kidney tumour ... Also known as: Hürthle cell (thyroid gland only) Oxyphilic cell, Askanazy cell, Apocrine metaplasia (breast gland only). ...
*  International Classification of Diseases for Oncology
Oxyphilic adenoma Oncocytic adenoma Oncocytoma Hurthle cell adenoma(C73.9) Hurthle cell tumor Follicular adenoma, oxyphilic ... Black adenoma Pigmented adenoma M8373/0 Adrenal cortical adenoma, clear cell (C74.0) M8374/0 Adrenal cortical adenoma, ... oxyphilic cell (C73.9) M8300/0 Basophil adenoma (C75.1) Mucoid cell adenoma M8300/3 Basophil carcinoma (C75.1) Basophil ... NOS Pick tubular adenoma Sertoli cell adenoma Tubular androblastoma, NOS Testicular adenoma M8640/3 Sertoli cell carcinoma (C62 ...
*  Chief cell
"Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas". BMC endocrine disorders. 7: 8. doi:10.1186/1472- ...
*  List of MeSH codes (C04)
... adenoma, liver cell MeSH C04.557.470.035.140 --- adenoma, oxyphilic MeSH C04.557.470.035.155 --- adenoma, pleomorphic MeSH ... adenoma, acidophil MeSH C04.557.470.035.075 --- adenoma, basophil MeSH C04.557.470.035.085 --- adenoma, bile duct MeSH C04.557. ... adenoma, acidophil MeSH C04.557.465.625.650.075 --- adenoma, basophil MeSH C04.557.465.625.650.095 --- adenoma, chromophobe ... adenoma, acidophil MeSH C04.557.580.625.650.075 --- adenoma, basophil MeSH C04.557.580.625.650.095 --- adenoma, chromophobe ...
*  Hürthle cell
A Hürthle cell adenoma or a minimally invasive tumor can be treated by a thyroid lobectomy, although some surgeons will perform ... Although the terms oncocyte, oxyphilic cell, and Hürthle cell are used interchangeably, Hürthle cell is used only to indicate ... Hürthle cell adenomas are most likely diagnosed much more frequently than Hürthle cell carcinomas. The female to male ratio for ... Adenoma Oncocytoma Oxyphil cell "Endocrine Pathology". Retrieved 2009-05-07. Aytug, Serhat (June 13, 2006). "Hurthle Cell ...
The Thyroid Hurthle (Oncocytic) Cell and Its Associated Pathologic Conditions: A Surgical Pathology and Cytopathology Review -...  The Thyroid Hurthle (Oncocytic) Cell and Its Associated Pathologic Conditions: A Surgical Pathology and Cytopathology Review -...
Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior.World J Surg. 1992; 16: ... Benign Hurthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma. Int J Surg ... Oxyphilic (Askenasy/Hurthle cell) tumors of the thyroid: microscopic features predict biologic behavior. Surg Pathol. 1988;1: ... Flow cytometric analysis of DNA content in Hurthle cell adenomas and carcinomas of the thyroid. Am J Clin Pathol. 1988;89:764- ...
more infohttp://www.redorbit.com/news/science/1538235/the_thyroid_hurthle_oncocytic_cell_and_its_associated_pathologic_conditions/
Oxyphilic adenoma  Oxyphilic adenoma
Build: Fri Jul 27 09:23:34 EDT 2018 (commit: a5c8d99). National Center for Advancing Translational Sciences (NCATS), 6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-435-0888. ...
more infohttps://pharos.nih.gov/idg/diseases/DOID:5389
Oxyphilic cell adenoma of parathyroid resulting in primary hyperparathyroidism and osteitis fibrosa cystica--a case report.  Oxyphilic cell adenoma of parathyroid resulting in primary hyperparathyroidism and osteitis fibrosa cystica--a case report.
... ... Parathyroid adenomas composed predominantly or exclusively of oxyphil cells are rare and most oxyphil cell adenomas of this ... Adenomas of the parathyroid gland, the majority of which are of the solitary chief cell type, are the most frequent cause of ... We present here a case of hyperfunctioning oxyphil cell adenoma of the parathyroid gland resulting in pHPT, osteitis fibrosa ...
more infohttp://www.ijpmonline.org/article.asp?issn=0377-4929
General Transcription Factors
     Summary Report | CureHunter  General Transcription Factors Summary Report | CureHunter
Oxyphilic Adenoma (Oncocytoma) 06/01/2012 - "Three microRNAs and 12 mRNA genes had a ≥98% coding region contained within CNV ...
more infohttp://www.curehunter.com/public/keywordSummaryD035165-General-Transcription-Factors.do
adenocarcinoma of endocrine gland diagnosis 2005:2010[pubdate] *count=100 - BioMedLib™ search engine  adenocarcinoma of endocrine gland diagnosis 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
Adenoma, Oxyphilic / pathology. Biomarkers, Tumor / analysis. Carcinoma, Papillary, Follicular / pathology. Peptide Library. ... Enomoto K, Sakurai K, Amano S: [Experience of parathyroid cancer which required a differentiation from adenoma]. Gan To Kagaku ... Adenoma / diagnosis. Parathyroid Neoplasms / diagnosis. *[MeSH-minor] Biomarkers, Tumor / analysis. Cell Nucleus / chemistry. ... Adenoma / diagnosis. Parathyroid Neoplasms / diagnosis. *[MeSH-minor] Aged. Diagnosis, Differential. Humans. ...
more infohttp://www.bmlsearch.com/?kwr=adenocarcinoma+of+endocrine+gland+diagnosis+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
International Classification of Diseases for Oncology  International Classification of Diseases for Oncology
8290/0 Oxyphilic adenoma. Synonyms. Oncocytic adenoma. Oncocytoma. Related terms. Hurthle cell tumor. Follicular adenoma, ...
more infohttp://codes.iarc.fr/code/412
Oncocytoma - Wikipedia  Oncocytoma - Wikipedia
The salivary gland oncocytoma is a well-circumscribed, benign neoplastic growth also called an oxyphilic adenoma. It comprises ... Thyroid oncocytomas can be benign (adenomas) or malignant (carcinomas). Grossly, oncocytic adenomas are encapsulated, solid ... The gross appearance of a minimally invasive oncocytic carcinoma is indistinguishable to that of an adenoma, while widely ... There are no reliable cytologic features which distinguish oncocytic adenomas from carcinomas and the only criterion for a ...
more infohttps://en.wikipedia.org/wiki/Oncocytoma
Contemporary Surgical Management of Renal Oncocytoma: A nations outcome  - UCL Discovery  Contemporary Surgical Management of Renal Oncocytoma: A nation's outcome - UCL Discovery
intraoperative complications, nephrectomy, oxyphilic adenoma, postoperative complications, renal oncocytoma. UCL classification ...
more infohttp://discovery.ucl.ac.uk/10043212/
benign tumor of submandibular gland 2005:2010[pubdate] *count=100 - BioMedLib™ search engine  benign tumor of submandibular gland 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
MeSH-major] Adenoma, Oxyphilic / pathology. Cell Transformation, Neoplastic. Submandibular Gland Neoplasms / pathology ... Adenoma, Pleomorphic / genetics. Adenoma, Pleomorphic / metabolism. Adenoma, Pleomorphic / pathology. Blotting, Western. ... Title] Sebaceous adenoma of the submandibular gland: a case report.. *Sebaceous adenoma of the salivary gland is a rare tumor ... Title] Pleomorphic adenoma of the submandibular gland.. *Pleomorphic adenomas of the submandibular glands are exceedingly rare ...
more infohttp://www.bmlsearch.com/?kwr=benign+tumor+of+submandibular+gland+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: Utility for distinguishing...  Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: Utility for distinguishing...
TY - JOUR. T1 - Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography. T2 - Utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. AU - Pierorazio, Phillip Martin. AU - Hyams, Elias S.. AU - Tsai, Salina. AU - Feng, Zhaoyong. AU - Trock, Bruce. AU - Mullins, Jeffrey K.. AU - Johnson, Pamela. AU - Fishman, Elliot K. AU - Allaf, Mohamad E. PY - 2013/6. Y1 - 2013/6. N2 - Objective: To analyze the enhancement patterns of small renal masses (SRMs) during 4-phase computed tomography (CT) imaging to predict histology. Methods: One-hundred consecutive patients with SRMs and 4-phase preoperative CT imaging, who underwent extirpative surgery with a pathologic diagnosis of renal cell carcinoma (RCC), angiomyolipoma (AML), or oncocytoma, were identified from a single institution. An expert radiologist, blinded to histologic results, retrospectively recorded tumor size, RENAL (radius, exophytic/endophytic properties of the ...
more infohttps://jhu.pure.elsevier.com/en/publications/multiphasic-enhancement-patterns-of-small-renal-masses-4-cm-on-pr-4
Hurthle cell tumor | definition of Hurthle cell tumor by Medical dictionary  Hurthle cell tumor | definition of Hurthle cell tumor by Medical dictionary
Called also oxyphilic adenoma of thyroid gland. ... Hürthle cell adenoma - a follicular adenoma of the thyroid in ... See also: Hürthle cell adenoma. Synonym(s): Hürthle cell carcinoma. Hürthle, Karl W., German histologist, 1860-1945. Hürthle ... Such tumors are usually benign (Hürthle cell adenoma) but on occasion may be locally invasive or may rarely metastasize ( ... large oxyphilic, eosinophilic cells found in the thyroid gland. They are metabolically altered follicular cells which ...
more infohttps://medical-dictionary.thefreedictionary.com/Hurthle+cell+tumor
Genevisible - Top 10 perturbations for NM 000220  Genevisible - Top 10 perturbations for NM 000220
tumor) / adjacent kidney tissue, oxyphilic adenoma study 1 / normal kidney tissue, clear cell renal cell carcinoma study 4 ( ... oxyphilic adenoma study 1 / normal kidney tissue. Relative Expression (log2-ratio):-6.4502783. Number of Samples:4 / 3 ... Tumor tissue samples from the kidney of patients with oxyphilic adenoma (renal oncocytoma).. ...
more infohttps://genevisible.com/perturbations/HS/RefSeq/NM_000220
Oncocyte - Wikipedia  Oncocyte - Wikipedia
... may be found as a less common salivary gland neoplasm also known as Oxyphilic Adenoma. Renal oncocytoma, a kidney tumour ... Also known as: Hürthle cell (thyroid gland only) Oxyphilic cell, Askanazy cell, Apocrine metaplasia (breast gland only). ...
more infohttps://en.wikipedia.org/wiki/Oncocyte
Plus it  Plus it
12 Synonyms for this tumor include oncocytic adenoma, oxyphilic granular-cell adenoma, and oxyphilic adenoma. ... Bilateral and multifocal parotid tumors on CT also render pleomorphic adenomas and basal cell adenomas less likely differential ... a feature seen mainly with pleomorphic adenomas but also in Warthin tumors and basal cell adenomas.2,17,32,33 Three of our ... basal cell adenomas, and, to a lesser degree, pleomorphic adenomas. However, when taken together, the diagnosis of a benign ...
more infohttp://www.ajnr.org/content/31/8/1413
Targets  Targets
Oxyphilic adenoma. 1 , 21 Peptic ulcer disease. 1 , 11 Psychotic Disorders. 1 , 20 ...
more infohttps://pharos.nih.gov/idg/targets?facet=Grant+Application/2R01DC001362-23
Agnew, D. W.<...  Agnew, D. W.<...
Armstrong, D. L., McGowen, M. R., Weckle, A., Pantham, P., Caravas, J., Agnew, D., Benirschke, K., Savage-Rumbaugh, S., Nevo, E., Kim, C. J., Wagner, G. P., Romero, R. & Wildman, D. E. Sep 1 2017 In : Placenta. 57, p. 71-78 8 p.. Research output: Research - peer-review › Article ...
more infohttps://scholars.opb.msu.edu/en/persons/dalen-w-agnew-2
adrenal glands  adrenal glands
Adenoma, Oxyphilic. 2. + + +. 39. Neoplasms, Complex and Mixed. 2. + + +. 40. Adenomatoid Tumor. 2. + + +. ...
more infohttps://lookfordiagnosis.com/results.php?symptoms=adrenal+glands&lang=1&parent=%2F&mode=F